Source: BEFREE

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 83932
Gene Symbol: SPRTN
SPRTN
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders 		0.040 Biomarker BEFREE Lasmiditan demonstrated superiority to placebo in the acute treatment of migraine in adults with moderate/severe migraine disability in two similarly designed Phase 3 trials, SAMURAI and SPARTAN. 31744319

2020
Entrez Id: 83932
Gene Symbol: SPRTN
SPRTN
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders 		0.040 Biomarker BEFREE SAMURAI and SPARTAN were double-blind, placebo-controlled Phase 3 studies in which individuals with migraine were randomized to oral lasmiditan 50 mg (SPARTAN only), 100 mg, 200 mg, or placebo. 31409292

2019
Entrez Id: 83932
Gene Symbol: SPRTN
SPRTN
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders 		0.040 Biomarker BEFREE Individuals with migraine were randomized to receive oral lasmiditan 50 mg (SPARTAN only), 100 mg, 200 mg, or placebo within 4 hours of onset of a migraine attack. 31152441

2019
Entrez Id: 83932
Gene Symbol: SPRTN
SPRTN
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders 		0.040 Biomarker BEFREE Patients were randomized to treat a migraine attack with oral lasmiditan 50 mg (SPARTAN only), 100 mg, 200 mg, or placebo. 31340760

2019